Tear osmolarity and dry eye symptoms in women using oral contraception and contact lenses

Cornea

Volumn 32, Issue 4, 2013, Pages 423-428

  Chen, Sarah P ^a   Massaro Giordano, Giacomina ^a   Pistilli, Maxwell ^a   Schreiber, Courtney A ^b   Bunya, Vatinee Y ^a  

^a Departments of Ophthalmology   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

contact lenses; dry eye; oral contraceptives; tear osmolarity

Indexed keywords

ESTROGEN; ORAL CONTRACEPTIVE AGENT; PROGESTERONE;

ADULT; ARTICLE; CLINICAL ASSESSMENT; CONTACT LENS; CONTROLLED STUDY; DRY EYE; FEMALE; FOLLICULAR PHASE; HUMAN; LUTEAL PHASE; MAJOR CLINICAL STUDY; MEDICAL HISTORY; MENSTRUATION; OCULAR SURFACE DISEASE; ORAL CONTRACEPTION; OSMOLARITY; PRIORITY JOURNAL; QUESTIONNAIRE;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; CONTACT LENSES; CONTRACEPTIVES, ORAL, HORMONAL; DRY EYE SYNDROMES; FEMALE; HUMANS; OSMOLAR CONCENTRATION; TEARS; YOUNG ADULT;

EID: 84875210363     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0b013e3182662390     Document Type: Article

References (38)

1. Schaumberg DA, Sullivan DA, Dana MR. Epidemiology of dry eye syndrome. Adv Exp Med Biol. 2002; 506:989-998.
2. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye Work-Shop (2007). Ocul Surf. 2007; 5:75-92.
3. Sullivan DA. Tearful relationships? Sex, hormones, the lacrimal gland, and aqueous-deficient dry eye. Ocul Surf. 2004; 2:92-123.
4. Schaumberg DA, Buring JE, Sullivan DA, et al. Hormone replacement therapy and dry eye syndrome. JAMA. 2001; 286:2114-2119.
5. Sullivan DA, Yamagami H, Lui M, et al. Sex steroids, the meibomian gland and evaporative dry eye. Adv Exp Med Biol. 2002; 506(pt A): 389-399.
6. Soni PS. Effects of oral contraceptive steroids on the thickness of human cornea. Am J Optom Physiol Opt. 1980; 57:825-834.
7. Frankel SH, Ellis PP. Effect of oral contraceptives on tear production. Ann Ophthalmol. 1978; 10:1585-1588.
8. Tomlinson A, Pearce EI, Simmons PA, et al. Effect of oral contraceptives on tear physiology. Ophthalmic Physiol Opt. 2001; 21:9-16.
9. Chalmers RL, Begley CG. Dryness symptoms among an unselected clinical population with and without contact lens wear. Cont Lens Anterior Eye. 2006; 29:25-30.
10. Begley CG, Caffery B, Nichols K, et al. Results of a dry eye questionnaire from optometric practices in North America. Adv Exp Med Biol. 2002; 506(pt B):1009-1016.
11. Brennan NA, Efron N. Symptomatology of HEMA contact lens wear. Optom Vis Sci. 1989; 66:834-838.
12. Ruben M. Contact lenses and oral contraceptives [Letter]. Br Med J. 1966; 1:1110.
13. De Vries Reilingh A, Reiners H, Van Bijsterveld OP. Contact lens tolerance and oral contraceptives. Ann Ophthalmol. 1978; 10:947-952.
14. Goldberg JB. A commentary on oral contraceptive therapy and contact lens wear. J Am Optom Assoc. 1970; 41:237-241.
15. Nichols JJ, Sinnott LT. Tear film, contact lens, and patient-related factors associated with contact lens-related dry eye. Invest Ophthalmol Vis Sci. 2006; 47:1319-1328.
16. Khanal S, Tomlinson A, McFadyen A, et al. Dry eye diagnosis. Invest Ophthalmol Vis Sci. 2008; 49:1407-1414.
17. Lemp MA, Bron AJ, Baudouin C, et al. Tear osmolarity in the diagnosis and management of dry eye disease. Am J Ophthalmol. 2011; 151: 792-798.
18. Sullivan BD, Whitmer D, Nichols KK, et al. An objective approach to dry eye disease severity. Invest Ophthalmol Vis Sci. 2010; 51:6125-6130.
19. Schiffman RM, Christianson MD, Jacobsen G. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol. 2000; 118:615-621.
20. Schaumberg DA, Gulati A, Mathers WD, et al. Development and validation of a short global dry eye symptom index. Ocul Surf. 2007; 5: 50-57.
21. Rivera R, Yacobson I, Grimes D. The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices. Am J Obstet Gynecol. 1999; 181(5 pt 1):1263-1269.
22. Serrander AM, Peek KE. Changes in contact lens comfort related to the menstrual cycle and menopause. A review of articles. J Am Optom Assoc. 1993; 64:162-166.
23. Versura P, Fresina M, Campos EC. Ocular surface changes over the menstrual cycle in women with and without dry eye. Gynecol Endocrinol. 2007; 23:385-390.26.
24. Giuffrè G, Di Rosa L, Fiorino F, et al. Variations in central corneal thickness during the menstrual cycle in women. Cornea. 2007; 26: 144-146.
25. Seymenoglu G, Baser EF, Zerdeci N, et al. Corneal biomechanical properties during the menstrual cycle. Curr Eye Res. 2011; 36:399-403.
26. Chiazze L Jr, Brayer FT, Macisco JJ Jr, et al. The length and variability of the human menstrual cycle. JAMA. 1968; 203:377-380.
27. Schaumberg DA, Sullivan DA, Buring JE, et al. Prevalence of dry eye syndrome among US women. Am J Ophthalmol. 2003; 136:318-326.
28. Gilbard JP, Gray KL, Rossi SR. A proposed mechanism for increased tear-film osmolarity in contact lens wearers. Am J Ophthalmol. 1986; 102: 505-507.
29. Stahl U, Willcox MD, Naduvilath T, et al. Influence of tear film and contact lens osmolality on ocular comfort in contact lens wear. Optom Vis Sci. 2009; 86:857-867.
30. Villani E, Ceresara G, Beretta S, et al. In vivo confocal microscopy of meibomian glands in contact lens wearers. Invest Ophthalmol Vis Sci. 2011; 52:5215-5219.
31. Arita R, Itoh K, Inoue K, et al. Contact lens wear is associated with decrease of meibomian glands. Ophthalmology. 2009; 116:379-384.
32. Pisella PJ, Malet F, Lejeune S, et al. Ocular surface changes induced by contact lens wear. Cornea. 2001; 20:820-825.
33. Miller WL, Doughty MJ, Narayanan S, et al. A comparison of tear volume (by tear meniscus height and phenol red thread test) and tear fluid osmolality measures in non-lens wearers and in contact lens wearers. Eye Contact Lens. 2004; 30:132-137.
34. Nichols JJ, Ziegler C, Mitchell GL, et al. Self-reported dry eye disease across refractive modalities. Invest Ophthalmol Vis Sci. 2005; 46: 1911-1914.
35. Versura P, Profazio V, Campos EC. Performance of tear osmolarity compared to previous diagnostic tests for dry eye diseases. Curr Eye Res. 2010; 35:553-564.
36. Nichols KK, Nichols JJ, Mitchell GL. The lack of association between signs and symptoms in patients with dry eye disease. Cornea. 2004; 23: 762-770.
37. Khanal S, Millar TJ. Barriers to clinical uptake of tear osmolarity measurements. Br J Ophthalmol. 2012; 96:341-344.
38. Sullivan BD, Crews LA, Sönmez B, et al. Clinical utility of objective tests for dry eye disease: variability over time and implications for clinical trials and disease management [epub ahead of print April 3, 2012]. Cornea. 2012.